We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DOL:TSXDollarama Inc. Analysis

Data as of 2026-08-08 - not real-time

CA$192.57

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

Dollarama Inc. trades at CAD 192.57, with its moving averages tangled rather than clearly stacked — a neutral trend structure. With RSI at 59.6 the momentum picture is neutral, alongside a bullish MACD signal. Recent trading has carved out support near CAD 181.05 and resistance around CAD 194.37.
The shares look overvalued at 39.7 times earnings, though no sector average was available for comparison. Consensus targets land 7.8% above where the shares trade now. Revenue is growing at 21.4% on a 17.6% profit margin. The 0.23% dividend yield looks covered by current payout levels.
Risk scores 3 out of 10, which is low for this asset class. With 30-day volatility of 17.2%, a beta of 0.19 and a maximum drawdown of 19.1%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.

Top Market Events

It's been a good week for Dollarama Inc. TSE:DOL shareholders, because the company has just released its latest...Dollarama TSX:DOL looks like a wise growth buy as inflation and headwinds intensify in the second half of 2026.Stockhouse1monDOLLARAMA ANNOUNCES RENEWAL OF NORMAL COURSE ISSUER BIDMONTRÉAL, July 3, 2026 /CNW/ - Dollarama Inc.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Trading above the 200-day average of 187.68
  • MACD momentum is positive
  • RSI at 59.6 is in neutral territory

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 187.68
  • Analyst targets imply +7.8% versus the current price
  • MACD momentum is positive

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • Analyst targets imply +7.8% versus the current price
  • Profit margin of 17.6% is healthy
  • Revenue growth of +21.4%

Key Metrics & Analysis

Financial Health

Revenue Growth21.40%
Profit Margin17.65%
P/E Ratio39.7
ROE99.47%
ROA15.02%
Debt/Equity451.25
P/B Ratio38.1
Op. Cash FlowCA$1.8B
Free Cash FlowCA$1.1B

Technical Analysis

TrendNeutral
RSI59.6
SupportCA$181.05
ResistanceCA$194.37
MA 20CA$188.58
MA 50CA$186.30
MA 200CA$187.68
MACDBullish
VolumeStable
Fear & Greed Index94.82

Valuation

Fair ValueCA$99.76
Target PriceCA$207.63
Upside/Downside7.82%
GradeOvervalued
TypeGrowth
Dividend Yield0.23%

Risk Assessment

Beta0.19
Volatility17.22%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.